Evidence map›Paper›PMID 36916610›Full record

ArticleAnalytical chemistry2023

Expanding the Epitranscriptomic RNA Sequencing and Modification Mapping Mass Spectrometry Toolbox with Field Asymmetric Waveform Ion Mobility and Electrochemical Elution Liquid Chromatography.

Richard Lauman, Hee Jong Kim, Lindsay K Pino, Alessandro Scacchetti, Yixuan Xie, Faith Robison, Simone Sidoli, Roberto Bonasio, Benjamin A Garcia

Abstract read
In one paragraph

Article in Analytical chemistry, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Epitranscriptomic Mass Spectrometry.Methods in molecular biology (Clifton, N.J.) · 2024
    Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Richard LaumanDepartment of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6243, United States.ORCID 0000-0002-2473-6413
Hee Jong KimDepartment of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6243, United States.ORCID 0000-0002-0823-5301
Lindsay K PinoDepartment of Biochemistry and Biophysics, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6243, United States.ORCID 0000-0003-1857-7222
Alessandro ScacchettiEpigenetic Institute and Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6243, United States.
Yixuan XieDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110-1010, United States.ORCID 0000-0002-8512-6053
Faith RobisonDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110-1010, United States.
Simone SidoliDepartment of Biochemistry, Albert Einstein College of Medicine, Bronx, New York 10461-1900, United States.
Roberto BonasioEpigenetic Institute and Department of Cell and Developmental Biology, University of Pennsylvania, Philadelphia, Pennsylvania 19104-6243, United States.
Benjamin A GarciaDepartment of Biochemistry and Molecular Biophysics, Washington University School of Medicine, St. Louis, Missouri 63110-1010, United States.ORCID 0000-0002-2306-1207

Funding

Shared Resources Core 2: Quantitative Proteomics CoreP01CA196539 · NCI · ROCKEFELLER UNIVERSITY · PI MAJEWSKI, JACEK · 2015 to 2024
$17.6M
Viral modulation of epitranscriptomic mechanismsR01AI118891 · NIAID · WASHINGTON UNIVERSITY · PI GARCIA, BENJAMIN A, WEITZMAN, MATTHEW D. · 2015 to 2025
$5.4M
Quantitative mass spectrometry for comprehending epigenetic mechanisms in a new underlying neurological developmental disorderR01HD106051 · NICHD · WASHINGTON UNIVERSITY · PI Benjamin A Garcia · 2022 to 2026
$2.6M
Regulation of PRC2 by protein and RNA interactions during differentiationR01GM138788 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BONASIO, ROBERTO · 2020 to 2023
$1.3M
Function and RNA-mediated regulation of SCMH1 in Polycomb repressionR01GM127408 · NIGMS · UNIVERSITY OF PENNSYLVANIA · PI BONASIO, ROBERTO · 2018 to 2021
$1.3M
Reconstitution and structural dissection of transcription-coupled histone H3.3 depositionF31AG069390 · NIA · UNIVERSITY OF PENNSYLVANIA · PI KIM, HEE JONG · 2020 to 2022
$126k
NCI NIH HHS P01 CA196539NIAID NIH HHS R01 AI118891NIA NIH HHS F31 AG069390NICHD NIH HHS R01 HD106051NIGMS NIH HHS R01 GM127408NIGMS NIH HHS R01 GM138788
6 · The paper itself

Abstract

Post-transcriptional modifications of RNA strongly influence the RNA structure and function. Recent advances in RNA sequencing and mass spectrometry (MS) methods have identified over 140 of these modifications on a wide variety of RNA species. Most next-generation sequencing approaches can only map one RNA modification at a time, and while MS can assign multiple modifications simultaneously in an unbiased manner, MS cannot accurately catalog and assign RNA modifications in complex biological samples due to limitations in the fragment length and coverage depth. Thus, a facile method to identify novel RNA modifications while simultaneously locating them in the context of their RNA sequences is still lacking. We combined two orthogonal modes of RNA ion separation before MS identification: high-field asymmetric ion mobility separation (FAIMS) and electrochemically modulated liquid chromatography (EMLC). FAIMS RNA MS increases both coverage and throughput, while EMLC LC-MS orthogonally separates RNA molecules of different lengths and charges. The combination of the two methods offers a broadly applicable platform to improve the length and depth of MS-based RNA sequencing while providing contextual access to the analysis of RNA modifications.

Indexed as

Ion Mobility SpectrometryRNABase SequenceChromatography, LiquidMass SpectrometryRNA

Identifiers

PMID36916610
PMCPMC10190205

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.